International Journal of Cancer Management

Published by: Kowsar

Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran

Hassan-Ali Vahedian-Ardakani 1 , Mansour Moghimi 2 , Mohammad Shayestehpour 3 , 4 , Masoud Doosti 5 and Fatemeh Alimohammadi 6 , *
Authors Information
1 Department of Internal Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Department of Pathology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
4 Autoimmune Research Center, Kashan University of Medical Sciences, Kashan, Iran
5 Infectious and Tropical Diseases Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
6 Aliebn- Abitaleb School of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran
Article information
  • International Journal of Cancer Management: May 2018, 11 (5); e61436
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: September 6, 2017
  • Revised: December 5, 2017
  • Accepted: March 5, 2018
  • DOI: 10.5812/ijcm.61436

To Cite: Vahedian-Ardakani H, Moghimi M, Shayestehpour M, Doosti M, Alimohammadi F. et al. Survival Rate of Patients with Bladder Cancer in Yazd, Central Province of Iran, Int J Cancer Manag. 2018 ; 11(5):e61436. doi: 10.5812/ijcm.61436.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Pakzad R, Mohammadian-Hafshejani A, Mohammadian M, Pakzad I, Safiri S, Khazaei S, et al. Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia. Asian Pac J Cancer Prev. 2015;16(16):7365-74. doi: 10.7314/APJCP.2015.16.16.7365. [PubMed: 26514538].
  • 2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0. [PubMed: 23245604].
  • 3. Rudman SM, Crawley D. Pathology and Epidemiology of Cancer. Epidemiology of Bladder Cancer. Springer; 2017. p. 511-22. doi: 10.1007/978-3-319-35153-7_27.
  • 4. Rezaianzadeh A, Mohammadbeigi A, Mobaleghi J, Mohammadsalehi N. Survival analysis of patients with bladder cancer, life table approach. J Midlife Health. 2012;3(2):88-92. doi: 10.4103/0976-7800.104468. [PubMed: 23372326].
  • 5. Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, Trends and Epidemiology of Cancers in North West of Iran. Asian Pac J Cancer Prev. 2015;16(16):7189-93. [PubMed: 26514510].
  • 6. Aliramaji A, Kaseean A, Yousefnia Pasha YR, Shafi H, Kamali S, Safari M, et al. Age distribution types of bladder cancers and their relationship with opium consumption and smoking. Caspian J Intern Med. 2015;6(2):82-6. [PubMed: 26221505].
  • 7. Shamsnia SJ, Khezri AA, Tabbatabaei HR, Mehrabani D. Survival from bladder cancer in Shiraz, Southern Iran: A hospital-based study. Middle East J Sci Res. 2013;18(4):425-31. doi: 10.5829/idosi.mejsr.2013.18.4.7542.
  • 8. Manterola C, Vial M, Roa JC. Survival of a cohort of patients with intermediate and advanced gall bladder cancer treated with a prospective therapeutic protocol. Acta Cir Bras. 2010;25(3):225-30. doi: 10.1590/S0102-86502010000300003. [PubMed: 20498934].
  • 9. Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ. 2011;(162):257-91. [PubMed: 21675431].
  • 10. Hashibe M, Gao T, Li G, Dalbagni G, Zhang ZF. Comparison of bladder cancer survival among Japanese, Chinese, Filipino, Hawaiian and Caucasian populations in the United States. Asian Pac J Cancer Prev. 2003;4(3):267-73. [PubMed: 14507249].
  • 11. Zaitsu M, Toyokawa S, Tonooka A, Nakamura F, Takeuchi T, Homma Y, et al. Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry. Cancer Med. 2015;4(3):363-70. doi: 10.1002/cam4.379. [PubMed: 25533611].
  • 12. Horstmann M, Witthuhn R, Falk M, Stenzl A. Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med. 2008;5(4):385-94. doi: 10.1016/j.genm.2008.11.002. [PubMed: 19108811].
  • 13. Gulliford MC, Petruckevitch A, Burney PG. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ. 1991;303(6800):437-40. doi: 10.1136/bmj.303.6800.437. [PubMed: 1912834].
  • 14. Pang C, Guan Y, Li H, Chen W, Zhu G. Urologic cancer in China. Jpn J Clin Oncol. 2016;46(6):497-501. doi: 10.1093/jjco/hyw034. [PubMed: 27049022].
  • 15. Chung F, Liao P, Sun Y, Amirshahi B, Fazel H, Shapiro CM, et al. Perioperative practical experiences in using a level 2 portable polysomnography. Sleep Breath. 2011;15(3):367-75. doi: 10.1007/s11325-010-0340-9. [PubMed: 20232260].
  • 16. Greven KM, Solin LJ, Hanks GE. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer. 1990;65(4):908-12. doi: 10.1002/1097-0142(19900215)65:4<908::AID-CNCR2820650415>3.0.CO;2-Z. [PubMed: 2404564].
  • 17. McBain CA, Logue JP. Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery in the 21st century. Semin Radiat Oncol. 2005;15(1):42-8. doi: 10.1016/j.semradonc.2004.07.015. [PubMed: 15662606].
  • 18. Baharlou R, Ahmadi Vasmehjani A, Dehghani A, Ghobadifar MA, Khoubyari M. Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer. Immune Netw. 2014;14(3):156-63. doi: 10.4110/in.2014.14.3.156. [PubMed: 24999312].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments